CITIUS ONCOLOGY, INC.CTOREarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
Citius Oncology, Inc. is a late-stage biopharmaceutical company focused on developing innovative targeted therapies for cancer patients. Its core pipeline covers treatments addressing unmet medical needs in hematologic malignancies and solid tumors, primarily serving North American and global oncology care markets.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| Mizuho Financial Group, Inc. | 5.84% | 522.0K | — | 2024-02-13 |
| Space Summit Capital LLC | 0.00% | 8.9M | — | 2024-02-05 |
| Wolverine Asset Management, LLC | 0.00% | 8.7K | ▼ -6.34pp | 2024-09-05 |
| This | 0.00% | 8.7K | ▼ -5.64pp | 2024-03-07 |
| Hudson Bay Capital Management LP | 0.00% | — | — | 2024-11-06 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
No transactions match these filters.